Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02905435 · ClinicalTrials.gov registry record · NA
Assessment of Safety and Effectiveness of Biodegradable Temporizing Matrix in the Treatment of Deep Burn Skin Injuries
A NA study of Burns, sponsored by PolyNovo Biomaterials Pty.
- Completed
- Registry status
- NA
- Development phase
- 15
- Enrollment target
- 5
- Study locations
NCT02905435 is a NA study of Burns that has completed, run by PolyNovo Biomaterials Pty. The registered enrollment target is 15 participants, below the 83-participant average among 36 other Burns trials with a reported enrollment target (82% lower). The trial reports 5 study locations across 5 states.
The verdict
NCT02905435, a NA study of Burns, has completed, sponsored by PolyNovo Biomaterials Pty.
- COMPLETED
- Registry status
- NA
- Development phase
- 15 participants
- Enrollment target
- 5
- Study locations
Study Summary
This is a multi-center, single arm, traditional feasibility study to allow a preliminary assessment of the safety and effectiveness of a new method of treating skin burns using Biodegradable Temporizing Matrix (BTM).
Conditions Studied
Interventions
- DEVICE Biodegradable Temporizing Matrix
Study Locations (5)
Arizona
- Arizona Burn Center at Maricopa Medical Center - Phoenix
California
- University of California Davis Medical Center - Sacramento
Florida
- Tampa General Hospital - Tampa
North Carolina
- Wake Forest University Health Sciences - Winston-Salem
Tennessee
- University of Tennessee Health Science Center - Memphis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2016-11-05 |
| Est. Completion | 2019-09-18 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02905435
The ClinicalTrials.gov registry entry for NCT02905435 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 83-participant average among 36 other Burns trials with a reported enrollment target (82% lower). The listed sponsor is PolyNovo Biomaterials Pty, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Burns appearing as the primary indexed condition, and to 1 intervention - of which Biodegradable Temporizing Matrix is the first listed.
NCT02905435 reports 5 study locations spanning 5 distinct geographic areas - top geographies include Arizona, California, Florida.
Frequently Asked Questions
What is clinical trial NCT02905435 about?
NCT02905435 is a clinical study titled "Assessment of Safety and Effectiveness of Biodegradable Temporizing Matrix in the Treatment of Deep Burn Skin Injuries". This is a multi-center, single arm, traditional feasibility study to allow a preliminary assessment of the safety and effectiveness of a new method of treating skin burns using Biodegradable Temporizing Matrix (BTM).
What is the current status of trial NCT02905435?
This trial is currently completed. It is a NA study. The enrollment target is 15 participants. The study started on 2016-11-05. Estimated completion is 2019-09-18.
What conditions does trial NCT02905435 study?
This clinical trial studies the following conditions: Burns.
What interventions are being tested in trial NCT02905435?
The interventions under investigation include: Biodegradable Temporizing Matrix (DEVICE).
Who is sponsoring clinical trial NCT02905435?
This trial is sponsored by PolyNovo Biomaterials Pty, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02905435 being conducted?
This trial has 5 study locations across Arizona, California, Florida, North Carolina, Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Burns
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Suprathel® Use During Prolonged Field Care to Promote Healing and Reduce the Need for Grafting of Burn Wounds
RECRUITING · NA
-
Impact of a Telerehabilitation Program With Technology Enhancement on Post-burn Recovery
RECRUITING · NA
-
Assessment of Safety and Effectiveness of NovoSorb® BTM in Severe Burns
ACTIVE NOT RECRUITING · NA
-
Conditioning & Open-Label Placebo (COLP) for Opioid Management in Intensive Inpatient Rehabilitation
ACTIVE NOT RECRUITING · NA
-
Virtual Reality in Burn Pain Management
COMPLETED · NA
-
Randomized Control Trial of CO2 Laser to Treat Hypertrophic Burn Scar
COMPLETED · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.